The plasma theophylline concentrations produced by 4 different slow release formulations, Theograd, Theodur, Theolair-SR and Rona-slophylline were measured over a 24-hr period in 8 healthy subjects. All 4 preparations maintained plasma levels over 12 hr and had similar AUC values when the difference in theophylline content was taken into account. Paired saliva and plasma theophylline concentrations gave a ratio of 1: 038, saliva: plasma, but with a large inter and intra individual variation.
Introduction
When administered in standard tablet formulations, theophylline has a plasma elimination half-life of about 6 hr (Trembath and Boobis, 1979) and therefore requires 6-or 8-hourly administration to maintain adequate therapeutic plasma concentrations (6) (7) (8) (9) (10) (11) (12) Lmol/l 
Results
The results are summarized in Table 1 12 and 24 hr than those produced by Theograd and Theodur (P < 0 02 and 0-06 respectively). The mean area under the curve (AUC) values for Theograd and Theodur were higher than those for Theolair-SR and Rona-slophylline over the 24-hr period and when extrapolated to infinity. Paired plasma and salivary concentrations for all formulations are shown in Fig. 2 . The regression line does not pass through zero. For all data, mean salivary concentration = 0-38 x plasma concentration + 1-49 (r=049, P<0001).
All preparations were well tolerated and no major adverse effects were noted by any subject. Two subjects complained of headache and fine tremor after Theodur, and one subject of fine tremor after Rona-slophylline. No complaints were made after Theograd or Theolair-SR.
Discussion
The purpose of this study was to determine if the pharmacokinetic properties of the 4 preparations were such that 12 hourly administration would result in therapeutically-active plasma concentrations. Their different theophylline contents made it difficult Slow release theophyline to compare them directly, but it is nevertheless possible to derive certain conclusions from the observations. Theolair-SR gave the earliest mean peak plasma concentration and Theodur the latest. Theodur gave later peak plasma concentrations and sustained higher concentrations until 12 hr compared with Theograd, even though its theophylline content was 300 mg compared with 350 mg in Theograd. Theodur showed the highest bioavailability and Rona-slophylline the lowest. When AUC values were recalculated on the basis of equivalent dosage, however, Theograd showed the lowest bioavailability while Theodur retained first position, although the differences were not statistically significant. In fact, visual inspection of Fig. 1 shows that there is little to choose between the 4 preparations in maintaining plasma levels over 12 hr and it would appear probable that 12 hourly administration should result in sustained therapeutic levels. This must be confirmed in longer term studies, however, which must include clinical assessment as well as plasma concentration estimations.
The large variation in plasma-salivary ratios confirms other observations and demonstrates that while salivary concentrations may provide a noninvasive guide to patient-compliance, they are of little value in studies of theophylline kinetics. preparations in normal subjects four slow-release theophylline A single-dose comparison of
